TRIESENBERG, Liechtenstein, Sept 7 (Bernama-BUSINESS WIRE) — Lysando, leading biotech in antimicrobial proteins, proudly announces the addition of Mr. Jorge Cortell to its esteemed Advisory Board marking a significant milestone in the company’s growth. As a serial entrepreneur and renowned visionary in healthcare technology he brings a wealth of expertise to Lysando’s strategic direction.
As Senior Advisor for Healthcare and Life Sciences at Harvard University Innovation Laboratories, and a technology advisor to NLC, Europe’s largest HealthTech Venture Builder, Jorge Cortell’s background positions him as a thought leader in the global industry. His profound understanding of both tech and business landscapes makes him an asset in guiding Lysando towards new heights of success.
